The atherectomy devices market size has grown strongly in recent years. It will grow from $0.85 billion in 2023 to $0.93 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to an increase in the elderly population, a rise in the incidence of cardiovascular conditions, increased funding and investment in cardiovascular research and healthcare infrastructure, rising obesity rates, and growing awareness of minimally invasive procedures.
The atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The projected growth during the forecast period can be attributed to rising diabetes rates, an increase in lifestyle-related diseases, greater availability of reimbursements for atherectomy systems, higher disposable incomes, and a growing demand for atherectomy procedures. Key trends expected in this period include ongoing innovations in atherectomy devices, the integration of advanced imaging technologies, a focus on patient-centric care, the implementation of robotic systems, and the use of real-time data analytics and machine learning.
The prevalence of coronary artery disease is expected to drive the growth of the atherectomy devices market. Coronary artery disease (CAD) is characterized by the narrowing or blockage of the coronary arteries due to plaque buildup, reducing blood flow to the heart. This increase in CAD prevalence is attributed to a global rise in the elderly population, sedentary lifestyles, higher levels of stress and mental health issues, and greater consumption of unhealthy foods. Directional coronary atherectomy, a minimally invasive procedure, is designed to remove blockages from coronary arteries, improving blood flow to the heart muscle and alleviating pain. For instance, according to the Centers for Disease Control and Prevention, the percentage of adults aged 18 and over with coronary heart disease (a condition where plaque builds up inside the coronary arteries) increased from 4.6% in 2020 to 4.9% in 2021. Additionally, the percentage of adults aged 18 and over with angina rose from 1.5% in 2021 to 1.6% in 2022. Therefore, the rising prevalence of coronary artery disease is fueling the growth of the atherectomy devices market.
Major companies in the atherectomy devices market are developing innovative products, such as atherectomy peripheral platform-based catheters, to gain a competitive advantage. These catheters are used to treat peripheral artery disease by navigating through blood vessels to address arterial blockages in the legs. For example, in October 2023, Cardio Flow, a US-based medical device manufacturer, launched the FreedomFlow, an orbital atherectomy peripheral platform. The FreedomFlow platform uses a modern mechanism to remove plaque blockages in the leg arteries, employing a proprietary catheter-based design that utilizes angular momentum physics. This design features a spiral geometry with five diamond-coated spheres that maintain constant contact with the vessel wall during both advancement and retraction.
In April 2023, Abbott Laboratories, a US-based medical device manufacturer, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition bolsters Abbott's vascular portfolio, enhancing its ability to provide care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc., also based in the US, specializes in producing innovative atherectomy systems.
Major companies operating in the atherectomy devices market are Cardinal Health Inc., Bayer AG, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Philips Healthcare, Boston Scientific Corporation, Merit Medical Systems Inc., Terumo Corporation, Cook Medical LLC, Integer Holdings Corporation, Biotronik SE & Co. KG, Penumbra Inc., Biomerics LLC, Asahi Intecc Co. Ltd., Volcano Corporation, AngioDynamics Inc., Cordis Corporation, Straub Medical AG, Avinger Inc., Cardio Flow Inc., Eximo Medical Ltd., Ra Medical Systems Inc., Acotec Scientific Holdings Ltd., ArioMedica Ltd.
North America was the largest region in the atherectomy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Atherectomy devices are specialized medical tools employed in atherectomy procedures, a minimally invasive surgery designed to eliminate atherosclerotic plaque from blood vessels. These devices are essential for treating arterial blockages, providing an accurate and minimally invasive method to restore blood flow and relieve symptoms related to peripheral artery disease (PAD) and coronary artery disease (CAD).
The primary types of atherectomy devices include rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and other related products. Rotational atherectomy devices are specialized tools designed to treat hardened, calcified plaques in arteries. These devices are used in various applications, including peripheral vascular, cardiovascular, and neurovascular applications. The end users encompass hospitals and surgical centers, ambulatory care centers, and other facilities.
The atherectomy devices market research report is one of a series of new reports that provides atherectomy devices market statistics, including the atherectomy devices industry global market size, regional shares, competitors with atherectomy devices market share, detailed atherectomy devices market segments, market trends, and opportunities, and any further data you may need to thrive in the atherectomy devices industry. This atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The atherectomy devices market consists of sales of laser atherectomy devices, hydrodynamic atherectomy devices, and ultrasonic atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The projected growth during the forecast period can be attributed to rising diabetes rates, an increase in lifestyle-related diseases, greater availability of reimbursements for atherectomy systems, higher disposable incomes, and a growing demand for atherectomy procedures. Key trends expected in this period include ongoing innovations in atherectomy devices, the integration of advanced imaging technologies, a focus on patient-centric care, the implementation of robotic systems, and the use of real-time data analytics and machine learning.
The prevalence of coronary artery disease is expected to drive the growth of the atherectomy devices market. Coronary artery disease (CAD) is characterized by the narrowing or blockage of the coronary arteries due to plaque buildup, reducing blood flow to the heart. This increase in CAD prevalence is attributed to a global rise in the elderly population, sedentary lifestyles, higher levels of stress and mental health issues, and greater consumption of unhealthy foods. Directional coronary atherectomy, a minimally invasive procedure, is designed to remove blockages from coronary arteries, improving blood flow to the heart muscle and alleviating pain. For instance, according to the Centers for Disease Control and Prevention, the percentage of adults aged 18 and over with coronary heart disease (a condition where plaque builds up inside the coronary arteries) increased from 4.6% in 2020 to 4.9% in 2021. Additionally, the percentage of adults aged 18 and over with angina rose from 1.5% in 2021 to 1.6% in 2022. Therefore, the rising prevalence of coronary artery disease is fueling the growth of the atherectomy devices market.
Major companies in the atherectomy devices market are developing innovative products, such as atherectomy peripheral platform-based catheters, to gain a competitive advantage. These catheters are used to treat peripheral artery disease by navigating through blood vessels to address arterial blockages in the legs. For example, in October 2023, Cardio Flow, a US-based medical device manufacturer, launched the FreedomFlow, an orbital atherectomy peripheral platform. The FreedomFlow platform uses a modern mechanism to remove plaque blockages in the leg arteries, employing a proprietary catheter-based design that utilizes angular momentum physics. This design features a spiral geometry with five diamond-coated spheres that maintain constant contact with the vessel wall during both advancement and retraction.
In April 2023, Abbott Laboratories, a US-based medical device manufacturer, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition bolsters Abbott's vascular portfolio, enhancing its ability to provide care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc., also based in the US, specializes in producing innovative atherectomy systems.
Major companies operating in the atherectomy devices market are Cardinal Health Inc., Bayer AG, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Philips Healthcare, Boston Scientific Corporation, Merit Medical Systems Inc., Terumo Corporation, Cook Medical LLC, Integer Holdings Corporation, Biotronik SE & Co. KG, Penumbra Inc., Biomerics LLC, Asahi Intecc Co. Ltd., Volcano Corporation, AngioDynamics Inc., Cordis Corporation, Straub Medical AG, Avinger Inc., Cardio Flow Inc., Eximo Medical Ltd., Ra Medical Systems Inc., Acotec Scientific Holdings Ltd., ArioMedica Ltd.
North America was the largest region in the atherectomy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Atherectomy devices are specialized medical tools employed in atherectomy procedures, a minimally invasive surgery designed to eliminate atherosclerotic plaque from blood vessels. These devices are essential for treating arterial blockages, providing an accurate and minimally invasive method to restore blood flow and relieve symptoms related to peripheral artery disease (PAD) and coronary artery disease (CAD).
The primary types of atherectomy devices include rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and other related products. Rotational atherectomy devices are specialized tools designed to treat hardened, calcified plaques in arteries. These devices are used in various applications, including peripheral vascular, cardiovascular, and neurovascular applications. The end users encompass hospitals and surgical centers, ambulatory care centers, and other facilities.
The atherectomy devices market research report is one of a series of new reports that provides atherectomy devices market statistics, including the atherectomy devices industry global market size, regional shares, competitors with atherectomy devices market share, detailed atherectomy devices market segments, market trends, and opportunities, and any further data you may need to thrive in the atherectomy devices industry. This atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The atherectomy devices market consists of sales of laser atherectomy devices, hydrodynamic atherectomy devices, and ultrasonic atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Atherectomy Devices Market Characteristics3. Atherectomy Devices Market Trends and Strategies32. Global Atherectomy Devices Market Competitive Benchmarking33. Global Atherectomy Devices Market Competitive Dashboard34. Key Mergers and Acquisitions in the Atherectomy Devices Market
4. Atherectomy Devices Market - Macro Economic Scenario
5. Global Atherectomy Devices Market Size and Growth
6. Atherectomy Devices Market Segmentation
7. Atherectomy Devices Market Regional and Country Analysis
8. Asia-Pacific Atherectomy Devices Market
9. China Atherectomy Devices Market
10. India Atherectomy Devices Market
11. Japan Atherectomy Devices Market
12. Australia Atherectomy Devices Market
13. Indonesia Atherectomy Devices Market
14. South Korea Atherectomy Devices Market
15. Western Europe Atherectomy Devices Market
16. UK Atherectomy Devices Market
17. Germany Atherectomy Devices Market
18. France Atherectomy Devices Market
19. Italy Atherectomy Devices Market
20. Spain Atherectomy Devices Market
21. Eastern Europe Atherectomy Devices Market
22. Russia Atherectomy Devices Market
23. North America Atherectomy Devices Market
24. USA Atherectomy Devices Market
25. Canada Atherectomy Devices Market
26. South America Atherectomy Devices Market
27. Brazil Atherectomy Devices Market
28. Middle East Atherectomy Devices Market
29. Africa Atherectomy Devices Market
30. Atherectomy Devices Market Competitive Landscape and Company Profiles
31. Atherectomy Devices Market Other Major and Innovative Companies
35. Atherectomy Devices Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Atherectomy Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for atherectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atherectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Rotational Atherectomy Devices; Orbital Atherectomy Devices; Directional Atherectomy Devices; Other Products2) By Application: Peripheral Vascular Applications; Cardiovascular Applications; Neurovascular Applications
3) By End User: Hospitals And Surgical Centers; Ambulatory Care Centers; Other End Users
Key Companies Mentioned: Cardinal Health Inc.; Bayer AG; Abbott Laboratories; Medtronic plc; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardinal Health Inc.
- Bayer AG
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson and Company
- Philips Healthcare
- Boston Scientific Corporation
- Merit Medical Systems Inc.
- Terumo Corporation
- Cook Medical LLC
- Integer Holdings Corporation
- Biotronik SE & Co. KG
- Penumbra Inc.
- Biomerics LLC
- Asahi Intecc Co. Ltd.
- Volcano Corporation
- AngioDynamics Inc.
- Cordis Corporation
- Straub Medical AG
- Avinger Inc.
- Cardio Flow Inc.
- Eximo Medical Ltd.
- Ra Medical Systems Inc.
- Acotec Scientific Holdings Ltd.
- ArioMedica Ltd
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | July 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 0.93 Billion |
Forecasted Market Value ( USD | $ 1.33 Billion |
Compound Annual Growth Rate | 9.5% |
Regions Covered | Global |